3250EGP
- Active ingredient
- ombitasvir+paritaprevir+ritonavir
- Strength
- 12.5/75/50mg
- Form
- tablet
- Manufacturer
- abbvie ltd.
- Route
- oral.solid
Uses
Antiviral combination used for treatment of chronic hepatitis C infection in appropriate patients.
Do not use if
Severe hepatic impairment or use with certain interacting medications.
Side effects
Fatigue, nausea, itching, insomnia, or elevated liver enzymes may occur.
Warnings
Monitor liver function and review potential drug interactions carefully.
How it works
Combines direct-acting antiviral agents targeting hepatitis C viral replication.
Storage
Store at room temperature.